Virus News and Research

Latest Virus News and Research

New study suggests most monoclonal antibody treatments are ineffective against Omicron SARS-CoV-2 variant

The arrival of the Omicron (B.1.1.529) variant has brought into question the effectiveness of current COVID-19 treatments in preventing infection and death. New research published in the preprint bioRxiv* server suggests the efficacy of most monoclonal antibody treatments are ineffective against Omicron.

20 Dec 2021

Scientists develop first photo-electrochemical aptasensor to detect SARS-CoV-2 virus in saliva

Scientists at the Universidad Carlos III de Madrid (UC3M) have developed the first photo-electrochemical aptasensor that detects the SARS-CoV-2 virus in a saliva sample.

20 Dec 2021

New Omicron variant may be better at evading vaccine-induced antibodies, research shows

The Omicron variant of SARS-CoV-2 may be significantly better than previous variants at evading vaccine-induced antibodies, according to new research from Cambridge - but preliminary evidence suggests it is less likely to cause severe COVID-19 illness in the lungs.

20 Dec 2021

£316 million funding boost to protect tens of thousands of people from homelessness

Tens of thousands of people will be protected from homelessness as a result of a £316 million funding boost, announced by the Department for Levelling Up, Housing and Communities today (21 December 2021).

20 Dec 2021

Omicron variant of SARS-CoV-2 exhibits striking antibody evasion

Researchers discuss the likely impact on current convalescent therapies and immunity of vaccinated individuals against the SARS-CoV-2 Omicron variant.

20 Dec 2021

Lung memory B-cells provide primary protection against SARS-CoV-2 reinfection

Researchers study influenza and SARS-CoV-2 infection models to identify lung memory B cells during viral infection.

20 Dec 2021

Long-read RNA sequencing identifies important host immune responses during SARS-CoV-2 infection

Researchers conduct a comprehensive in vitro analysis of relatively unexplored host immune responses during SARS-CoV-2 infection.

20 Dec 2021

White-tailed deer are efficient carriers of SARS-CoV-2

Researchers demonstrate the susceptibility of white-tailed deer to SARS-CoV-2.

20 Dec 2021

Reduced antibody-mediated neutralization by the SARS-CoV-2 Omicron variant

Researchers discuss the sensitivity of the SARS-CoV-2 Omicron variant towards various monoclonal antibodies.

20 Dec 2021

£28 million government funding boost to protect and vaccinate rough sleepers

Rough sleepers are being helped to get their COVID-19 vaccines and move into safe accommodation over the winter thanks to a £28 million government funding boost, the Department for Levelling Up, Housing and Communities announced today (20 December 2021).

20 Dec 2021

Computational analysis of the effect of SARS-CoV-2 Omicron variant spike protein mutations

A new study highlights the potential evolutionary trade-off observed in the omicron variant, detailing the dynamics of the protein structure, its interactions, and subsequent effects.

20 Dec 2021

A test to identify antibody effectiveness against COVID-19 variants

Since the start of the COVID-19 pandemic, variants have begun to emerge. We spoke to Jacob Heggestad about his rapid test that can detect these variants.

20 Dec 2021

Study suggests SARS-CoV-2 Omicron variant RBM binding may be weaker than in wild-type

A new study shows that the Omicron variant binds to the ACE2 receptor in a significantly weaker manner than other variants and the wild-type.

20 Dec 2021

Vaccine promoters struggle to get people boosted in California’s fields

Since the start of the pandemic, Luz Gallegos and her team of 56 advocates for immigrants have battled the scorching sun, illiteracy and deadly propaganda in the fields and fruit groves of the Coachella Valley.

20 Dec 2021

The vaccine rollout was a success. But events within and beyond Biden’s control stymied progress.

Eleven months ago, President Joe Biden assumed office during one of the most critical moments of the covid-19 pandemic. Case counts and death rates were shockingly high.

20 Dec 2021

Impact of SARS-CoV-2 variants in unvaccinated and vaccinated U.S. military personnel

A new study helps to explain the rapid spread of the Delta variant and provides the impetus to increase control measures including vaccine boosters and social distancing requirements.

20 Dec 2021

Humanized mice reveals why few COVID-19 cases are more severe than others

Why do 80 to 90% of people infected with COVID-19 experience only mild cases while 10 to 20% face more severe or life-threatening symptoms?

20 Dec 2021

REACT-1 study shows COVID boosters and first doses in children are providing important protection

The Real-time Assessment of Community Transmission-1 (REACT-1) study has been tracking the transmission of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) throughout England since May 2020. SARS-CoV-2 is the cause of the ongoing coronavirus disease 2019 (COVID-19) pandemic.

19 Dec 2021

A nematode infection can become severe and deadly with the use of corticosteroids

Healthcare workers in tropical and sub-tropical settings where strongyloidiasis is prevalent or caring for patients who have travelled to such areas, need to maintain a high level of awareness about the use of corticosteroids, including when this class of anti-inflammatories is given to patients suspected of infection with SARS-CoV-2.

19 Dec 2021

Efficacy of SARS-CoV2 variant-specific replicating RNA vaccines on SARS-CoV-2 variants of concern

A new study evaluates the repRNA vaccine expressing the SARS-CoV-2 spike protein for the B.1.1.7 and B.1.351 variants in mice and hamsters.

19 Dec 2021

Virus News and Research

Latest Virus News and Research

New study suggests most monoclonal antibody treatments are ineffective against Omicron SARS-CoV-2 variant

Scientists develop first photo-electrochemical aptasensor to detect SARS-CoV-2 virus in saliva

New Omicron variant may be better at evading vaccine-induced antibodies, research shows

£316 million funding boost to protect tens of thousands of people from homelessness

Omicron variant of SARS-CoV-2 exhibits striking antibody evasion

Lung memory B-cells provide primary protection against SARS-CoV-2 reinfection

Long-read RNA sequencing identifies important host immune responses during SARS-CoV-2 infection

White-tailed deer are efficient carriers of SARS-CoV-2

Reduced antibody-mediated neutralization by the SARS-CoV-2 Omicron variant

£28 million government funding boost to protect and vaccinate rough sleepers

Computational analysis of the effect of SARS-CoV-2 Omicron variant spike protein mutations

A test to identify antibody effectiveness against COVID-19 variants

Study suggests SARS-CoV-2 Omicron variant RBM binding may be weaker than in wild-type

Vaccine promoters struggle to get people boosted in California’s fields

The vaccine rollout was a success. But events within and beyond Biden’s control stymied progress.

Impact of SARS-CoV-2 variants in unvaccinated and vaccinated U.S. military personnel

Humanized mice reveals why few COVID-19 cases are more severe than others

REACT-1 study shows COVID boosters and first doses in children are providing important protection

A nematode infection can become severe and deadly with the use of corticosteroids

Efficacy of SARS-CoV2 variant-specific replicating RNA vaccines on SARS-CoV-2 variants of concern

A new way of characterising biomolecules eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Virus News and Research

Latest Virus News and Research

A new way of characterising biomolecules eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in